Heffeter P - Search Results

1

The calcium-sensing receptor modulates the prostaglandin E₂ pathway in intestinal inflammation.

Gushchina V, Kupper N, Schwarzkopf M, Frisch G, Piatek K, Aigner C, Michel A, Schueffl H, Iamartino L, Elajnaf T, Manhardt T, Vlasaty A, Heffeter P, Bassetto M, Kállay E, Schepelmann M. Gushchina V, et al. Among authors: heffeter p. Front Pharmacol. 2023 Apr 20;14:1151144. doi: 10.3389/fphar.2023.1151144. eCollection 2023. Front Pharmacol. 2023. PMID: 37153788 Free PMC article.

2

Differences in protein binding and excretion of Triapine and its Fe(III) complex.

Pelivan K, Miklos W, van Schoonhoven S, Koellensperger G, Gille L, Berger W, Heffeter P, Kowol CR, Keppler BK. Pelivan K, et al. Among authors: heffeter p. J Inorg Biochem. 2016 Jul;160:61-9. doi: 10.1016/j.jinorgbio.2015.10.006. Epub 2015 Oct 19. J Inorg Biochem. 2016. PMID: 26507768

3

High Copper Complex Stability and Slow Reduction Kinetics as Key Parameters for Improved Activity, Paraptosis Induction, and Impact on Drug-Resistant Cells of Anticancer Thiosemicarbazones.

Hager S, Pape VFS, Pósa V, Montsch B, Uhlik L, Szakács G, Tóth S, Jabronka N, Keppler BK, Kowol CR, Enyedy ÉA, Heffeter P. Hager S, et al. Among authors: heffeter p. Antioxid Redox Signal. 2020 Aug 20;33(6):395-414. doi: 10.1089/ars.2019.7854. Epub 2020 Jun 9. Antioxid Redox Signal. 2020. PMID: 32336116

4

Landomycins as glutathione-depleting agents and natural fluorescent probes for cellular Michael adduct-dependent quinone metabolism.

Terenzi A, La Franca M, van Schoonhoven S, Panchuk R, Martínez Á, Heffeter P, Gober R, Pirker C, Vician P, Kowol CR, Stoika R, Salassa L, Rohr J, Berger W. Terenzi A, et al. Among authors: heffeter p. Commun Chem. 2021 Nov 25;4(1):162. doi: 10.1038/s42004-021-00600-4. Commun Chem. 2021. PMID: 36697631 Free PMC article.

5

Vanadium(IV/V) complexes of Triapine and related thiosemicarbazones: Synthesis, solution equilibrium and bioactivity.

Kowol CR, Nagy NV, Jakusch T, Roller A, Heffeter P, Keppler BK, Enyedy ÉA. Kowol CR, et al. Among authors: heffeter p. J Inorg Biochem. 2015 Nov;152:62-73. doi: 10.1016/j.jinorgbio.2015.08.023. Epub 2015 Sep 1. J Inorg Biochem. 2015. PMID: 26349014

6

Application of C60 Fullerene-Doxorubicin Complex for Tumor Cell Treatment In Vitro and In Vivo.

Panchuk RR, Prylutska SV, Chumakl VV, Skorokhyd NR, Lehka LV, Evstigneev MP, Prylutskyy YI, Berger W, Heffeter P, Scharff P, Ritter U, Stoika RS. Panchuk RR, et al. Among authors: heffeter p. J Biomed Nanotechnol. 2015 Jul;11(7):1139-52. doi: 10.1166/jbn.2015.2058. J Biomed Nanotechnol. 2015. PMID: 26307837

7

Thiosemicarbazone Derivatives Developed to Overcome COTI-2 Resistance.

Pósa V, Stefanelli A, Nunes JHB, Hager S, Mathuber M, May NV, Berger W, Keppler BK, Kowol CR, Enyedy ÉA, Heffeter P. Pósa V, et al. Among authors: heffeter p. Cancers (Basel). 2022 Sep 14;14(18):4455. doi: 10.3390/cancers14184455. Cancers (Basel). 2022. PMID: 36139615 Free PMC article.

8

Specific antioxidant compounds differentially modulate cytotoxic activity of doxorubicin and cisplatin: in vitro and in vivo study.

Panchuk R, Skorokhyd N, Chumak V, Lehka L, Omelyanchik S, Gurinovich V, Moiseenok A, Heffeter P, Berger W, Stoika R. Panchuk R, et al. Among authors: heffeter p. Croat Med J. 2014 Jun 1;55(3):206-17. doi: 10.3325/cmj.2014.55.206. Croat Med J. 2014. PMID: 24891279 Free PMC article.

9

Quantitative bioimaging by LA-ICP-MS: a methodological study on the distribution of Pt and Ru in viscera originating from cisplatin- and KP1339-treated mice.

Egger AE, Theiner S, Kornauth C, Heffeter P, Berger W, Keppler BK, Hartinger CG. Egger AE, et al. Among authors: heffeter p. Metallomics. 2014 Sep;6(9):1616-25. doi: 10.1039/c4mt00072b. Metallomics. 2014. PMID: 24823867

10

Enhanced anticancer activity and circumvention of resistance mechanisms by novel polymeric/ phospholipidic nanocarriers of doxorubicin.

Senkiv Y, Riabtseva A, Heffeter P, Boiko N, Kowol CR, Jungwith U, Shlyakhtina Y, Garasevych SG, Mitina N, Berger W, Zaichenko A, Stoika R. Senkiv Y, et al. Among authors: heffeter p. J Biomed Nanotechnol. 2014 Jul;10(7):1369-81. doi: 10.1166/jbn.2014.1864. J Biomed Nanotechnol. 2014. PMID: 24804557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

161 results

Search Page